Literature DB >> 225672

The src gene product of transformed and morphologically reverted ASV-infected mammalian cells.

M S Collett, J S Brugge, R L Erikson, A F Lau, R A Krzyzek, A J Faras.   

Abstract

Morphological revertants of avian sarcoma virus transformed vole cells contain the sarcoma gene product (pp60src) in an enzymatically active form, suggesting that the presence of pp60src protein kinase activity is infussicient to induce morphological transformation. Structural analyses of pp60src from infected vole cell clones suggest that in one of the revertant clones on alteration in pp60src may be responsible for morphological reversion while in a second clone, reversion may result from an alteration in a cell gene product with which pp60src must interact. As these morphological revertant cells are tumorigenic, different cell components are required to interact with pp60src to facilitate the two events.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225672     DOI: 10.1038/281195a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  10 in total

1.  Intercellular communication and the control of growth: XI. Alteration of junctional permeability by the src gene in a revertant cell with normal cytoskeleton.

Authors:  R Azarnia; W R Loewenstein
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

2.  Association of pp60src and src protein kinase activity with the plasma membrane of nonpermissive and permissive avian sarcoma virus-infected cells.

Authors:  R A Krzyzek; R L Mitchell; A F Lau; A J Faras
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

3.  Correlation between phosphorylation of a 34,000-molecular-weight protein, pp60src-associated kinase activity, and tumorigenicity in transformed and revertant vole cells.

Authors:  J F Nawrocki; A F Lau; A J Faras
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

4.  Expression of Kirsten murine sarcoma virus in transformed nonproducer and revertant NIH/3T3 cells: evidence for cell-mediated resistance to a viral oncogene in phenotypic reversion.

Authors:  J D Norton; F Cook; P C Roberts; J P Clewley; R J Avery
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

5.  Specific proteolytic fragmentation of p60v-src in transformed cell lysates.

Authors:  S K Wells; M S Collett
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

6.  Transformation-defective mutants of feline sarcoma virus which express a product of the viral src gene.

Authors:  L Donner; L P Turek; S K Ruscetti; L A Fedele; C J Sherr
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

7.  Spontaneous conversion of nontransformed avian sarcoma virus-infected rat cells to the transformed phenotype.

Authors:  L P Turek; H Oppermann
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

8.  Detection of phosphotyrosine-containing 34,000-dalton protein in the framework of cells transformed with Rous sarcoma virus.

Authors:  Y S Cheng; L B Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

9.  Isolation and partial characterization of a monoclonal antibody to the Rous sarcoma virus transforming protein pp60src.

Authors:  S J Parsons; D J McCarley; C M Ely; D C Benjamin; J T Parsons
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

10.  Tubulin assembly sites and the organization of cytoplasmic microtubules in cultured mammalian cells.

Authors:  B R Brinkley; S M Cox; D A Pepper; L Wible; S L Brenner; R L Pardue
Journal:  J Cell Biol       Date:  1981-09       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.